Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Lilly names accomplished immunologist to its board of directors

By Brian Buntz | May 6, 2022

Eli LillyEli Lilly and Company (NYSE:LLY) has elected Mary Lynne Hedley as a new board member, starting May 15, 2022.

Hedley will serve on the board committees related to science and technology, and ethics and compliance.

Hedley is an immunologist and cancer cell biologist with substantial experience in the pharma industry.

Mary Lynne Hedley

Mary Lynne Hedley

Hedley has worked as a senior scientific fellow at the Broad Institute of MIT and Harvard and has served as director, president and chief operating officer of Tesaro, an oncology-focused biotech company she co-founded in 2010. Tesaro commercialized Zejula (niraparib), a PARP inhibitor used for ovarian cancer, fallopian tube and primary peritoneal cancer. GSK acquired Tesaro in 2019 for more than $5 billion.

In 2017, Hedley was awarded an EY Entrepreneurs of the Year Overall National Award.

Hedley has also held senior roles at the biotech Abraxis BioScience and Eisai Corp. of North America.

“I am delighted to welcome Dr. Mary Lynne Hedley to the Lilly Board of Directors,” said David A. Ricks, Lilly CEO, in a press release. “Mary Lynne has valuable expertise in oncology and the pharmaceutical industry more broadly. Her experience in founding, scaling, and leading biotechnology companies will add tremendous technological and leadership insight to our board.”

Tell Us What You Think! Cancel reply

Related Articles Read More >

Seagen
Seagen CEO Siegall resigns after domestic abuse arrest
Moderna
Moderna’s new CFO leaves after former employer discloses investigation
Pfizer logo
Pfizer to shell out $11.6B for migraine drugmaker Biohaven
Novartis logo
Novartis temporarily halts production of two radioligand therapy medicines

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards